The controversy is due to some studies reporting the expression of GLP-1R in human hepatocytes [49] and suggesting a role in decreasing hepatic steatosis [16, 43], while others failed to detect hepatic expression of GLP-1R [22, 23]. Here, GLP1R is linked to fatty liver disease.